Participants 60 116 3
men treated for symptomatic benign prostatic hyperplasia
Participants 205 313 4
sexual function in men with lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH).
Participants 373 445 4
men aged > or = 50 years, after a 28-day placebo run-in period, patients
Participants 679 798 7
A total of 372 patients were randomized to receive alfuzosin (n=186) or placebo (n=186), with 355 completing the study.
Participants 799 913 3
At baseline, 64% of the patients reported erectile dysfunction (ED) and 63% reported ejaculatory dysfunction (EjD)
